137 related articles for article (PubMed ID: 34407473)
1. Biomimetic matrix for the study of neuroblastoma cells: A promising combination of stiffness and retinoic acid.
Labat B; Buchbinder N; Morin-Grognet S; Ladam G; Atmani H; Vannier JP
Acta Biomater; 2021 Nov; 135():383-392. PubMed ID: 34407473
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix rigidity modulates neuroblastoma cell differentiation and N-myc expression.
Lam WA; Cao L; Umesh V; Keung AJ; Sen S; Kumar S
Mol Cancer; 2010 Feb; 9():35. PubMed ID: 20144241
[TBL] [Abstract][Full Text] [Related]
3. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
Cernaianu G; Brandmaier P; Scholz G; Ackermann OP; Alt R; Rothe K; Cross M; Witzigmann H; Tröbs RB
J Pediatr Surg; 2008 Jul; 43(7):1284-94. PubMed ID: 18639684
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan-based hydrogels as versatile tumor-like models: Tunable ECM and stiffness with genipin-crosslinking.
Bonnesœur S; Morin-Grognet S; Thoumire O; Le Cerf D; Boyer O; Vannier JP; Labat B
J Biomed Mater Res A; 2020 May; 108(5):1256-1268. PubMed ID: 32056374
[TBL] [Abstract][Full Text] [Related]
5. Status of topoisomerase-2β protein in all-trans retinoic acid-treated human neuroblastoma (SK-N-SH) cells.
Bhanothu V; Kondapi AK
J Cell Biochem; 2019 Apr; 120(4):5169-5182. PubMed ID: 30318608
[TBL] [Abstract][Full Text] [Related]
6. All-trans retinoic acid induces COX-2 and prostaglandin E2 synthesis in SH-SY5Y human neuroblastoma cells: involvement of retinoic acid receptors and extracellular-regulated kinase 1/2.
Alique M; Herrero JF; Lucio-Cazana FJ
J Neuroinflammation; 2007 Jan; 4():1. PubMed ID: 17204142
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of XAB2 enhances all-trans retinoic acid-induced cellular differentiation in all-trans retinoic acid-sensitive and -resistant cancer cells.
Ohnuma-Ishikawa K; Morio T; Yamada T; Sugawara Y; Ono M; Nagasawa M; Yasuda A; Morimoto C; Ohnuma K; Dang NH; Hosoi H; Verdin E; Mizutani S
Cancer Res; 2007 Feb; 67(3):1019-29. PubMed ID: 17283134
[TBL] [Abstract][Full Text] [Related]
8. Redox balance influences differentiation status of neuroblastoma in the presence of all-trans retinoic acid.
Silvis AM; McCormick ML; Spitz DR; Kiningham KK
Redox Biol; 2016 Apr; 7():88-96. PubMed ID: 26678800
[TBL] [Abstract][Full Text] [Related]
9. Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells.
Han G; Chang B; Connor MJ; Sidell N
Differentiation; 1995 Jul; 59(1):61-9. PubMed ID: 7589896
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.
Adamson PC
Leukemia; 1994; 8 Suppl 3():S22-5. PubMed ID: 7808020
[TBL] [Abstract][Full Text] [Related]
11. Expressional alterations in functional ultra-conserved non-coding RNAs in response to all-trans retinoic acid--induced differentiation in neuroblastoma cells.
Watters KM; Bryan K; Foley NH; Meehan M; Stallings RL
BMC Cancer; 2013 Apr; 13():184. PubMed ID: 23565812
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid induces neuroblastoma cell death by inhibiting proteasomal degradation of retinoic acid receptor alpha.
Nagai J; Yazawa T; Okudela K; Kigasawa H; Kitamura H; Osaka H
Cancer Res; 2004 Nov; 64(21):7910-7. PubMed ID: 15520197
[TBL] [Abstract][Full Text] [Related]
13. Bottom up proteomics reveals novel differentiation proteins in neuroblastoma cells treated with 13-cis retinoic acid.
Halakos EG; Connell AJ; Glazewski L; Wei S; Mason RW
J Proteomics; 2019 Oct; 209():103491. PubMed ID: 31472280
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis of N-type neuroblastoma cells after differentiation with 9-cis-retinoic acid and subsequent washout.
Lovat PE; Irving H; Annicchiarico-Petruzzelli M; Bernassola F; Malcolm AJ; Pearson AD; Melino G; Redfern CP
J Natl Cancer Inst; 1997 Mar; 89(6):446-52. PubMed ID: 9091647
[TBL] [Abstract][Full Text] [Related]
15. Elevated TrkA receptor expression is associated with all-trans retinoic acid-induced neuroblastoma differentiation.
Gao Q; Chen CF; Dong Q; Hou L; Chen X; Zhi YL; Li X; Lu HT; Zhang HY
Genet Mol Res; 2015 Oct; 14(4):13195-202. PubMed ID: 26535632
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of human SH-SY5Y neuroblastoma cells by all-trans retinoic acid activates the interleukin-18 system.
Sallmon H; Hoene V; Weber SC; Dame C
J Interferon Cytokine Res; 2010 Feb; 30(2):55-8. PubMed ID: 20028206
[TBL] [Abstract][Full Text] [Related]
17. Enhanced cell cycle perturbation and apoptosis mediate the synergistic effects of ST1926 and ATRA in neuroblastoma preclinical models.
Di Francesco AM; Ubezio P; Torella AR; Meco D; Pierri F; Barone G; Cusano G; Pisano C; D'Incalci M; Riccardi R
Invest New Drugs; 2012 Aug; 30(4):1319-30. PubMed ID: 21633925
[TBL] [Abstract][Full Text] [Related]
18. Reversible upregulation of tropomyosin-related kinase receptor B by geranylgeranoic acid in human neuroblastoma SH-SY5Y cells.
Sakane C; Shidoji Y
J Neurooncol; 2011 Sep; 104(3):705-13. PubMed ID: 21373967
[TBL] [Abstract][Full Text] [Related]
19. BMP-6 and retinoic acid synergistically differentiate the IMR-32 human neuroblastoma cells.
Sumantran VN; Brederlau A; Funa K
Anticancer Res; 2003; 23(2B):1297-303. PubMed ID: 12820386
[TBL] [Abstract][Full Text] [Related]
20. Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cells.
Veal GJ; Errington J; Redfern CP; Pearson AD; Boddy AV
Biochem Pharmacol; 2002 Jan; 63(2):207-15. PubMed ID: 11841795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
